FDA clears Medtronic robot for urologic surgeries, enabling use in prostatectomy, nephrectomy and cystectomy across select U.S. hospitals.

Robotic-assisted partial nephrectomy (RAPN) led to a lower rate of complications compared with open partial nephrectomy (OPN) in patients with intermediate- or high-complexity kidney tumors, the ...

Kidney cancer is among the most lethal of urologic malignancies. The rising incidence of kidney cancer is attributable to greater detection of incidental small renal masses (≤4 cm) from increased use ...

A systematic review with meta-analysis compared single- versus multi-port robotic approaches in prostate and renal surgery.

Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...

Single-port robotic surgery is an innovative approach in urological procedures that aims to minimize invasiveness while maintaining surgical effectiveness. This technique utilizes a single incision, ...

Please provide your email address to receive an email when new articles are posted on . Lower rates of adverse outcomes were linked to higher technical skill Surgeons with higher scores had lower ...

In the treatment of small renal masses, robotic partial nephrectomy (RPN) has a superior morbidity profile compared with laparoscopic partial nephrectomy (LPN), according to an updated meta-analysis ...

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

Medtronic (MDT) announced the FDA has cleared the Hugo robotic-assisted surgery, or RAS, system for use in urologic surgical procedures. The Hugo ...